PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseasesLankin, Vadim Z.; Tikhaze, Alla K.; Viigimaa, Margus; Chazova, Irina EvgenevnaTerapevticheskii Arkhiv2018 / p. 27-30 https://doi.org/10.26442/terarkh201890927-30 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS